ChinaTechSignals

Database

Funding Rounds

736 rounds tracked

▾
▾
$22MSeries B
Puyi Biotechbiotechhealthtech
17 Mar 2024

A biotech company specializing in nanopore gene sequencing technology with full-stack self-developed capabilities including nanopore protein modification, single-molecule base recognition, high-integration silicon-based chips, and high-fidelity signal acquisition systems.

Zhejiang Galaxy Guoke Consumer Health Equity Investment Fund, Wanfu Biotech, Changfa Development Group +more

Source →
UndisclosedPre-A
Langxi Technologyhardwaresemiconductor
16 Mar 2024

A company focused on developing high-capacitance silicon capacitor products and advanced packaging technologies for semiconductor applications.

Oriental Wealth Sea, Jinpu Intelligent

Source →
UndisclosedSeries C
Newbonbiobiotechhealthtech
16 Mar 2024

Newbonbio is a dietary supplement ingredient company focused on research and development of innovative functional raw materials using pharmaceutical-grade R&D approaches. The company operates across synthetic biology, chemical synthesis, plant extraction, and technical formulation to develop high-purity, high-stability products for weight management, muscle building, blood sugar control, anti-aging, brain health, and immune support.

Mingxi Capital, Guanggu Industrial Investment, Huaxi Yuanyou Fund

Source →
$29MSeries A
Tianwu Technologyaibiotech
16 Mar 2024

An AI-driven full-stack protein research and development platform company that uses large language models and automated experimental systems to design functional proteins for drug discovery, healthcare, agriculture, and biotech applications.

Yonghe Investment, China National Petroleum Corporation Kunlun Capital, New Supply and Marketing Fund, Farmer Kai +more

Source →
UndisclosedAngel
LingYu Roboticsairobotics
13 Mar 2024

An embodied AI company that develops general-purpose robotic operation solutions with human-machine collaborative intelligence, enabling robots with reliable and flexible manipulation capabilities for household applications.

Galaxy Innovation Capital, Inno Angel Fund, Telescope Ventures +more

Source →
$145MSeries B
PaXiniairobotics
6 Mar 2024

A global embodied perception-driven general intelligence company that develops high-precision tactile hardware and builds a human-centric high-precision data collection system, operating massive data acquisition factories to produce multimodal perception data.

Xin'an Capital, Huangpu River Capital, UNI-T, Haichuan Fund +more

Source →
$14MSeries B
Chengtian Technologyroboticsai
5 Mar 2024

An exoskeleton robotics company developing wearable exoskeleton products designed to enhance human mobility and address physical limitations, with applications across medical, athletic, entertainment, and consumer sectors.

Agricultural Bank of China Capital, Hangzhou Capital, Huichuan Production Investment

Source →
$29MPre-IPO
Immunoforge Biologicsbiotechhealthtech
4 Mar 2024

A global innovative cell therapy company focused on developing CAR-T cell therapies for solid tumors, with proprietary platforms including next-generation CAR-T technology and in vivo CAR-T generation technology.

Gaorong Capital, Jifeng Capital, Approx Medical Fund, Mingdao Investment +more

Source →
Undisclosedpre-c
Youmagic (Shuliti Research Company - Weimmai Medical)healthtechai
4 Mar 2024

Weimmai Medical is a research and development company specializing in energy medicine technology, particularly high-energy monopolar radiofrequency devices for aesthetic medicine. The company has developed an integrated platform for research, development, production, and sales of energy medicine solutions with proprietary technologies including pulse flash technology, dynamic intelligent temperature control, and AI energy impedance matching.

SBI (Shibai Yi)

Source →
UndisclosedSeries A
Juewu Technologyroboticsagritech
2 Mar 2024

A hard-tech company focused on developing heavy-load all-terrain modular deformable robots for agriculture and other outdoor work scenarios. The company designs unified robot chassis that can be adapted with different functional modules to handle complex field environments and diverse task requirements.

Huachuang Capital, Jiangxi Golden Control Capital

Source →
$72MSeries C
Zhitide Biologicsbiotechhealthtech
2 Mar 2024

A near-commercialization biotech company focused on developing innovative drugs for chronic metabolic diseases, leveraging proprietary E. coli production platforms and long-acting peptide technologies.

OrbiMed, Blue Horizon Ventures, WuYuan Capital +more

Source →
UndisclosedStrategic
Chromaihardwarebiotech
24 Feb 2024

Chromai is a leading domestic high-end liquid chromatography company that develops and produces ultra-high-performance liquid chromatography (UHPLC) systems and related analytical instruments for applications in pharmaceutical, food testing, environmental monitoring, and chemical analysis.

Beijing Municipal Pharmaceutical and Health Industry Investment Fund

Source →
UndisclosedSeed
Jingji Intelligentroboticshardware
20 Oct 2023

Jingji Intelligent is a cleaning robotics startup that focuses on cleaning vertical surfaces, countertops, and sanitary fixtures by applying force control and machine technology.

Shanghai Lanyun Industrial Development, Haowen Tianshu Robotics

Source →
$343MSeries C
Infinigence AIaihardware
12 Oct 2023

Infinigence AI develops software and infrastructure that allow AI models to run efficiently across different chip platforms.

UndisclosedSeries B
Pongbotaihardware
11 Oct 2023

PONGBOT is an AI sports-hardware company that develops sports-training robots, beginning with table-tennis training robots.

Shanghai State Investment Pilot Fund, Hua Capital

Source →